ArticleNature communications2025

In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis.

Beatriz Chaves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.